ASCO 2016

The American Society of Clinical Oncology (ASCO) will host its Annual Meeting on June 3-June 7, 2016, in Chicago, Illinois, at McCormick Place. This year's meeting, Collective Wisdom: The Future of Patient-Centered Care and Research, is focused on integrating care and involving all stakeholder voice to improve outcomes in cancer patients. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage


ASCO is conducting a clinical trial to evaluate how different targeted cancer drugs work to find additional uses outside its FDA indication.
Patients with lung cancer who reported symptoms via Moovcare showed 1-year survival of 75%.
The highest retail prices for 23 different cancer drugs was found in the United States.
Adding temozolomide (Temodar) to chemoradiation reduced the risk of death by 33% in elderly glioblastoma patients.
Aggressive treatment approach shows promise in children with high risk brain cancer.
Choosing Wisely recommendations have not substantially changed the care received by patients in the last 30 days of life.
Women diagnosed with breast cancer who carry a BRCA mutation have up to a 50% lifetime risk of developing a second breast cancer.
Rovalpituzumab tesirine reduced tumor growth and even shrank tumors in some patients with small cell lung cancer.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.